4D Molecular Therapeutics’ Post

Take advantage of critical insights to accelerate your EAP strategy! We’re partnering with Fierce Biotech to bring you an essential webinar on June 25th at 11 am ET / 4 pm UK. Topic: The Power of Expanded Access Programs and Pan-European Real-World Data Collection. Our panel of experts, Andrew Cummins and Mathieu Loiseau, will discuss how EAPs provide faster market access by establishing a network through early engagement with healthcare professionals and Key Opinion Leaders (KOLs). Additionally, utilizing real-world data gleaned from EAPs, to support future regulatory submissions and market positioning. Register Today: https://lnkd.in/gjZQC9HY #Webinar #FierceBiotech #EAPs #EuropeanMarket #RealWorldData #Biotech #MarketAccess

Join our Syneos Health Consulting team at JPM's Biotech Showcase next week in this panel discussion to learn more about how to invest for success in today's challenging environment!

In the realm of #biotechnology, precise drug-level detection is crucial for optimizing #patientcare. At NeoVentures, our ongoing research has yielded significant advancements in this area with the introduction of NeoMer #aptamers. 🧪 Key Highlights: Our Neomer aptamers provide enhanced accuracy and efficiency in #drugmonitoring. This technological advancement is pivotal in improving the safety and efficacy of treatments. 🌐 Broader Impact: This development is a testament to our commitment to evolving #healthcare into a more proactive, personalized domain. We’re proud to be at the forefront of #aptamerresearch, contributing to meaningful innovations in healthcare.

📊 NED Remuneration Report - ASX-Health & Biotechnology The 4th edition of Wexford Hayes annual NED Remuneration Report for FY23 is out now. Highly valued by Boards and CEOs throughout the sector, this report unveils insights into remuneration trends, providing a guide for navigating the dynamic remuneration landscape. 🌐💡 📹 Curious about the key takeaways? Dive into the attached video for an overview. 📥 Interested in staying ahead of the curve? Reach out for your copy to Wexford Hayes 📧👥 www.wexfordhayes.com #health #Biotech #LeadershipInsights #BusinessTrends #WexfordHayes #NEDRemuneration

💡 Why Most Biotech Companies Fail 💡 Most biotech companies fail because they rely on a single product. At Viome, we’re focused on creating a healthier future through natural health solutions that are already proven by nature. No risky drugs, no side effects—just personalized health for everyone. 🌍 #Biotech #NaturalHealth #HealthInnovation #Viome #PreventiveMedicine

https://lnkd.in/eF2XeB6a With the US election little over a month away, speculation about its impact on various sectors is increasing. This article discusses the election’s effect on the Medtech sector. #medtech #medicaldevice #healthtech #biotech #lifescience

📢 Attention pharma journalists attending this year's BIO International Convention. If you're lining up interviews or meet-ups and we haven't connected yet, I'd love to hear from you. ramarketing has several clients with exciting news to share. Drop me a DM and let's make it happen! 📢 #BIO2024 #Pharmajournalism #PharmaNews #Biotech #Lifesciences #Healthcareinnovation #Biotechnews #Networking #BioInternational #Pharmameetups #Industrynews #Pharmaevents

What characterizes an ideal, sustainable biosimilar market that improves patient #access to safe and high-quality biological #therapies and meets the interests of all stakeholders? IQVIA's white paper "The Impact of Biosimilar Competition in Europe" explores this and other questions. While the topic of #interchangeability plays a crucial role according to IQVIA, a balance of #access, #regulation, #competition and #incentive systems is most promising for a sustainable biosimilar market. Read more in the IQVIA white paper: https://lnkd.in/ePwm_ubw #Biosimilars #Market #Biotech #Sustainability #Healthcare #TeamFormycon #IQVIA #Whitepaper

The Unseen Environmental Cost of Pharmaceuticals In the modern world, pharmaceuticals offering relief and cure to many health conditions. Yet, beneath this healing facade lies an often-overlooked consequence—environmental pollution. The journey of pharmaceuticals, from their production to their disposal, demonstrates significant risks to different ecosystems, particularly aquatic life, and by extension, human health.  In this upcoming series of articles, Opticom will delve into the critical yet often overlooked issue of pharmaceutical waste and its environmental consequences. Our first piece sheds light on the significant barrier presented by a lack of public awareness regarding the safe disposal of unused or expired medications. This topic aligns with Opticom's commitment to fostering informed discussions and better solutions, as we explore the intersection of both healthcare and environmental sustainability. By initiating this series, Opticom aims to inspire actionable change, reflecting our dedication to addressing complex global challenges through insightful analysis and strategic guidance. Read the full article here https://lnkd.in/gQU7mPXE #betterdecisions #sustainability #pharmaceutical #pharma #environment #healthcare #pollution

Tony Sedgwick and I are looking forward to our next #AgileLeaders Forum in #London on Thursday 14 March produced with the kind support of Gill Jennings & Every LLP. Our #AgileLeaders "think-tank" debate focuses on "#cellandgenetherapies vs #smallmolecules." We will discuss the pros and cons of each when considering all factors - such as which is the most likely to deliver the most benefit to investors, patients, payers etc. Which side of the debate are you on? This event is for business leaders of #innovation #lifesciences companies - the #AgileLeaders concept is to learn from each other's experiences, build new peer-to-peer relationships, have fun and participate in stimulating cutting-edge debates. Full details and tickets on Eventbrite. For #AgileLeaders with #BiotechBuddies for business leaders: https://lnkd.in/e-FkVJRv For #BiotechBuddies only for everyone: https://lnkd.in/eeGMkwCq #biotech #biotechnology #biopharma #drugdevelopment #drugdiscovery #druginnovation #coffeebuddies